Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.1045
Abstract: In this open‐label, single‐dose, parallel‐group study, we compared the pharmacokinetic profile and safety of lobeglitazone, a thiazolidinedione acting as an agonist for peroxisome proliferator‐activated receptors, in patients with hepatic impairment (HI) and healthy matched controls… read more here.
Keywords: profile safety; safety lobeglitazone; lobeglitazone; pharmacokinetic profile ... See more keywords
Complication Profile and Safety Outcomes of Aquablation in the Management of BPH
Sign Up to like & getrecommendations! Published in 2025 at "Medicina"
DOI: 10.3390/medicina61122076
Abstract: Background and Objectives: Aquablation, a robot-assisted, heat-free resection technique, has emerged as a promising minimally invasive surgical therapy (MIST) for benign prostatic hyperplasia (BPH). Its precision and potential for preservation of sexual function distinguish it… read more here.
Keywords: aquablation; profile safety; bph; complication profile ... See more keywords